Surgery Partners, Inc. (SGRY)
USD 19.88
(-5.47%)
USD 19.88
(-5.47%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 328 Million USD | 18.34% |
| 2022 | 345.2 Million USD | 14.23% |
| 2021 | 302.2 Million USD | 22.55% |
| 2020 | 246.6 Million USD | 4.54% |
| 2019 | 235.9 Million USD | 203.07% |
| 2018 | 77.83 Million USD | -50.81% |
| 2017 | 158.23 Million USD | -19.47% |
| 2016 | 196.48 Million USD | 35.74% |
| 2015 | 144.75 Million USD | 184.91% |
| 2014 | 50.8 Million USD | -12.74% |
| 2013 | 58.22 Million USD | -3.68% |
| 2012 | 60.45 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 104.1 Million USD | -4.07% |
| 2024 Q1 | 88.4 Million USD | -37.57% |
| 2023 Q2 | 97.6 Million USD | 34.81% |
| 2023 Q1 | 72.4 Million USD | -48.36% |
| 2023 FY | 408.5 Million USD | 18.34% |
| 2023 Q4 | 141.6 Million USD | 71.43% |
| 2023 Q3 | 82.6 Million USD | -15.37% |
| 2022 Q3 | 74.1 Million USD | -3.14% |
| 2022 Q2 | 76.5 Million USD | 2.55% |
| 2022 Q4 | 140.2 Million USD | 89.2% |
| 2022 FY | 345.2 Million USD | 14.23% |
| 2022 Q1 | 74.6 Million USD | -35.02% |
| 2021 FY | 302.2 Million USD | 22.55% |
| 2021 Q1 | 64.3 Million USD | -33.23% |
| 2021 Q3 | 63.6 Million USD | 6.89% |
| 2021 Q4 | 114.8 Million USD | 80.5% |
| 2021 Q2 | 59.5 Million USD | -7.47% |
| 2020 Q3 | 18.5 Million USD | -58.61% |
| 2020 FY | 246.6 Million USD | 4.54% |
| 2020 Q1 | 23.5 Million USD | -67.27% |
| 2020 Q4 | 96.3 Million USD | 420.54% |
| 2020 Q2 | 44.7 Million USD | 90.21% |
| 2019 Q1 | 49.6 Million USD | 195.59% |
| 2019 Q4 | 71.8 Million USD | 21.69% |
| 2019 Q3 | 59 Million USD | 6.31% |
| 2019 Q2 | 55.5 Million USD | 11.9% |
| 2019 FY | 235.9 Million USD | 203.07% |
| 2018 Q4 | -51.88 Million USD | -215.3% |
| 2018 Q1 | 41.16 Million USD | -48.77% |
| 2018 Q2 | 43.56 Million USD | 5.83% |
| 2018 Q3 | 45 Million USD | 3.31% |
| 2018 FY | 77.83 Million USD | -50.81% |
| 2017 Q3 | 42.84 Million USD | 13.54% |
| 2017 FY | 158.23 Million USD | -19.47% |
| 2017 Q4 | 80.34 Million USD | 87.51% |
| 2017 Q2 | 37.73 Million USD | -9.54% |
| 2017 Q1 | 41.72 Million USD | -39.01% |
| 2016 FY | 196.48 Million USD | 35.74% |
| 2016 Q3 | 42.84 Million USD | -15.9% |
| 2016 Q4 | 68.4 Million USD | 59.65% |
| 2016 Q2 | 50.94 Million USD | 48.62% |
| 2016 Q1 | 34.28 Million USD | 62.25% |
| 2015 Q2 | 41 Million USD | 6.91% |
| 2015 Q1 | 38.35 Million USD | 1145.84% |
| 2015 FY | 144.75 Million USD | 184.91% |
| 2015 Q3 | 44.27 Million USD | 7.98% |
| 2015 Q4 | 21.12 Million USD | -52.28% |
| 2014 Q3 | 19.65 Million USD | -4.68% |
| 2014 Q1 | 16.41 Million USD | 0.0% |
| 2014 Q2 | 20.62 Million USD | 25.66% |
| 2014 FY | 50.8 Million USD | -12.74% |
| 2014 Q4 | -3.66 Million USD | -118.66% |
| 2013 FY | 58.22 Million USD | -3.68% |
| 2012 FY | 60.45 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 506.59 Million USD | 35.254% |
| Addus HomeCare Corporation | 90.95 Million USD | -260.614% |
| AirSculpt Technologies, Inc. | 9.48 Million USD | -3358.821% |
| Amedisys, Inc. | 156.39 Million USD | -109.727% |
| American Oncology Network, Inc. | -49.15 Million USD | 767.291% |
| Astrana Health, Inc. | 84.61 Million USD | -287.647% |
| Aveanna Healthcare Holdings Inc. | 8.07 Million USD | -3963.429% |
| IMAC Holdings, Inc. | -6.37 Million USD | 5244.688% |
| biote Corp. | 28.65 Million USD | -1044.572% |
| Cryo-Cell International, Inc. | -12.3 Million USD | 2765.793% |
| Cross Country Healthcare, Inc. | 112.71 Million USD | -191.005% |
| COMPASS Pathways plc | -136.91 Million USD | 339.558% |
| DocGo Inc. | 15.05 Million USD | -2078.681% |
| The Ensign Group, Inc. | 255.36 Million USD | -28.443% |
| Healthcare Services Group, Inc. | 62.35 Million USD | -425.995% |
| InnovAge Holding Corp. | -23.18 Million USD | 1515.013% |
| Assure Holdings Corp. | -20.08 Million USD | 1733.303% |
| The Joint Corp. | -2.07 Million USD | 15921.815% |
| LifeStance Health Group, Inc. | -189.13 Million USD | 273.422% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.7 Million USD | 2188.674% |
| ModivCare Inc. | -139.94 Million USD | 334.376% |
| NewGenIvf Group Limited | 42.24 Thousand USD | -776378.386% |
| Novo Integrated Sciences, Inc. | -8.55 Million USD | 3934.839% |
| Option Care Health, Inc. | 314.59 Million USD | -4.261% |
| P3 Health Partners Inc. | -167.86 Million USD | 295.401% |
| P3 Health Partners Inc. | -167.86 Million USD | 295.401% |
| The Pennant Group, Inc. | 25.16 Million USD | -1203.19% |
| Syra Health Corp. Class A Common Stock | -2.88 Million USD | 11458.918% |
| Talkspace, Inc. | -23.2 Million USD | 1513.245% |
| Talkspace, Inc. | -23.2 Million USD | 1513.245% |
| The Oncology Institute, Inc. | -77.01 Million USD | 525.874% |
| The Oncology Institute, Inc. | -77.01 Million USD | 525.874% |